Explore evidence

14.6 %The prevalence of major drug resistance mutations among 144 participants was 14.6%.

KenyaVIH/sidapublished 2021Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 6 observations

10,382 person_yearsIn Gem, HIV incidence was estimated over 10,382 person-years.

KenyaVIH/sidapublished 2021PLoS medicinePubMeddocument of 7 observations

2.85 ng/mLBaseline plasma ANG-2 levels were higher among five women who died after ART initiation than among women who did not, with medians of 2.85 ng/mL versus 1.32 ng/mL (p = 0.01).

KenyaVIH/sidapublished 2013BMC infectious diseaseseurope_pmcdocument of 3 observations

94.6 %Among HIV positive mothers, favourable attitudes regarding exclusive breastfeeding for HIV-exposed infants were 94.6% in the BFCI intervention arm and 53.8% in the control arm.

KenyaVIH/sidapublished 2020International breastfeeding journalPubMeddocument of 6 observations

0.2 hazard_ratioAge ≥40 years was associated with a lower pregnancy risk with an adjusted hazard ratio of 0.2 among female sex workers living with HIV in Mombasa, Kenya.

KenyaVIH/sidaobserved October 2012-April 2017published 2020Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 10 observations

53 %In Kenya, the viral load suppression improved from 53% to 88%.

KenyaVIH/sidapublished 2021BMC health services researchPubMeddocument of 5 observations

82.6 %Among 4708 PLHIV initiated on IPT in Kenya between July 2015 and June 2018, 3891 (82.6%) had IPT treatment outcomes documented.

KenyaVIH/sidaobserved July 2015 to June 2018published 2020PloS onePubMeddocument of 8 observations

30 %There was an overall 30% reduction in HIV prevalence among female sex workers in Kenya between 1993 and 2016.

KenyaVIH/sidaobserved 1993 to 2016published 2020International journal of STD & AIDSeurope_pmcdocument of 5 observations

72 %Among children living with HIV who were on treatment at the beginning of fiscal year 2022, aging out of childhood accounted for 72% of the total cohort reductions.

KenyaVIH/sidaobserved FY 2022published 2025The Pediatric infectious disease journalPubMeddocument of 10 observations

-14.69 per_100The HIV self-testing intervention was associated with a risk difference of -14.69 per 100 for lower HIV testing among participants with high fatalism.

KenyaVIH/sidapublished 2024AIDS and behaviorPubMeddocument of 2 observations

3,017 individualsIn Kisumu and Homa Bay counties in western Kenya, 3017 male sex partners (MSPs) of female index clients were mentioned for HIV assisted partner services between November 2018 and December 2020.

KenyaVIH/sidaobserved November 2018 to December 2020published 2023BMC health services researchPubMeddocument of 6 observations

5 %5% of HIV-1 transmission clusters were mixed between heterosexuals and female sex workers (HET/FSW).

KenyaVIH/sidaobserved 2005-2019published 2020Scientific reportsPubMeddocument of 9 observations

10 %Among 5155 women living with HIV in the analysis, 10% switched from dolutegravir to a non-nucleoside reverse transcriptase inhibitor-containing antiretroviral treatment within 12 months post-dolutegravir initiation.

KenyaVIH/sidapublished 2022Journal of the International AIDS SocietyPubMeddocument of 10 observations

Normochromic, macrocytic normochromic and dimorphic anaemias were observed in HIV infected patients.

Kenyaanémie · VIH/sidapublished 2017Kenyatta University Institutional Repository (Kenyatta University)OpenAlexdocument of 7 observations

27 %Women living with HIV had a 27% lower prevalence of continued breastfeeding with complementary feeding at 9-months than women without HIV.

KenyaVIH/sidapublished 2024International breastfeeding journalPubMeddocument of 6 observations

22 %The frequency of HIVDR mutations associated with tenofovir or emtricitabine among individuals diagnosed with HIV who had received PrEP was 22%.

KenyaVIH/sidapublished 2025Journal of the International AIDS SocietyPubMeddocument of 13 observations

46.8 %Among 7,046 individuals sampled starting antiretroviral therapy (ART) in Kenya, 3,296 (46.8%) had a viral load test done at a median 6.2 months after ART initiation.

KenyaVIH/sidapublished 2023PloS onePubMeddocument of 7 observations

36 %Of the 1,267 people living with HIV still on legacy antiretroviral regimens at one health facility in Kenya, 36% were determined to be eligible and prioritized to switch to optimized regimens.

KenyaVIH/sidapublished 2020PloS onePubMeddocument of 4 observations

1.23 relative_riskThe relative risk of first-time HIV testing when offering two HIV self-tests versus one was 1.23.

KenyaVIH/sidaobserved March 2021-June 2022published 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 5 observations

12 %A female sex worker who is 1 year older had 12% less HIV drug resistance mutations (HIVDRM), with an incidence rate ratio of 0.88.

KenyaVIH/sidapublished 2023MedicinePubMeddocument of 3 observations

6 odds_ratioHIV infection was associated with studying in private institutions (adjusted odds ratio = 6.0; 95% CI: 1.2–30.0, p = 0.027).

KenyaVIH/sidaobserved 2021published 2023AIDS research and therapyPubMeddocument of 14 observations

89.5 %HIV-1 subtype A1 accounted for 89.5% of all cases among female sex workers in Nairobi, Kenya.

KenyaVIH/sidaobserved November 2020 to April 2021published 2022MedicinePubMeddocument of 6 observations

69 %Among people with TB and HIV in Kenya between 2008 and 2018, 69% received antiretroviral therapy (ART).

Kenyatuberculose · VIH/sidaobserved 2008 to 2018published 2022The international journal of tuberculosis and lung disease : the official journal of the IPubMeddocument of 8 observations

71.6 %Among 901 women surveyed in fishing communities in Kenya, Tanzania, and Uganda from 2018 through 2019, 645 (71.6%) reported travelling, with 53.4% reporting short-term trips and 18.2% reporting long-term trips.

Kenya · Ouganda · TanzanieVIH/sidaobserved 2018 through 2019published 2023AIDS and behaviorPubMeddocument of 2 observations

58 %Reporting among facilities with diagnostic capacity was 58% for HIV and 52% for malaria.

KenyaVIH/sidaobserved 2018published 2023BMC health services researchPubMeddocument of 7 observations